Literature DB >> 7084614

Electron and immunoelectron microscopic study of Dane particle formation in chronic hepatitis B virus infection.

G Yamada, Y Sakamoto, M Mizuno, T Nishihara, T Kobayashi, T Takahashi, H Nagashima.   

Abstract

The site of Dane particle formation in hepatocytes was studied by routine electron and immunoelectron microscopy of liver biopsy specimens from 10 patients with hepatitis B e antigen-positive chronic active hepatitis. With routine electron microscopy, core particles were abundant in cytosol, often adjacent to the cell membrane, and occasionally in the microvilli. Figures suggestive of budding of endoplasmic reticulum with a core particle into the cisternae of endoplasmic reticulum were observed frequently. There were also figures suggestive of direct budding with a core particle from the surface of the cell. With the immunoelectron microscopy, the core particles were found to be positive for hepatitis B core antigen and the endoplasmic reticulum and the plasma membrane were positive for hepatitis B surface antigen. These findings suggest that the most plausible mode of formation of the Dane particle is by budding of hepatitis B surface antigen-positive endoplasmic reticulum membrane into the cisternae. In addition, formation of the Dane particle may also take place at the surface of the hepatocyte by a similar mechanism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7084614

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  23 in total

1.  Abstracts of selected papers presented at the 30th annual meeting of the Japanese Society of Gastroenterology. October 20-22, 1988, Kagoshima, Japan.

Authors: 
Journal:  Gastroenterol Jpn       Date:  1990-08

2.  Hepatic lesions in alcoholic HBV carriers.

Authors:  T Takahashi; T Kamimura; H Asakura; F Ichida
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

3.  Immunohistochemical study of pre-S(2) antigen in liver and serum of patients with chronic hepatitis B.

Authors:  K Takaguchi; G Yamada; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1990-06

4.  Immunohistochemical study of HLA class 1 antigens on the hepatocytes of patients with chronic hepatitis B.

Authors:  K Manabe; G Yamada; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1986-08

5.  Cellular immune response in liver of patients with chronic hepatitis B. Electron microscopic observation of lymphocyte subsets by the immunoperoxidase method using monoclonal antibodies.

Authors:  G Yamada; T Nishihara; I Hyodo; K Manabe; S Fujiki; H Okushin; M Mizuno; S Kinoyama; T Kobayashi; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1984-12

6.  The ultrastructural morphology of native hepatitis B virus.

Authors:  Masahiko Kaito; Hiroyoshi Ohba; Joe Chiba; Michinori Kohara; Hideaki Tanaka; Naoki Fujita; Esteban Cesar Gabazza; Shozo Watanabe; Masayoshi Konishi; Yukihiko Adachi
Journal:  Med Mol Morphol       Date:  2006-09       Impact factor: 2.309

7.  Core antigen and antibody in woodchucks after infection with woodchuck hepatitis virus.

Authors:  A Ponzetto; P J Cote; E C Ford; R H Purcell; J L Gerin
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

8.  Alpha/beta interferon differentially modulates the clearance of cytoplasmic encapsidated replication intermediates and nuclear covalently closed circular hepatitis B virus (HBV) DNA from the livers of hepatocyte nuclear factor 1alpha-null HBV transgenic mice.

Authors:  Aimee L Anderson; Krista E Banks; Marco Pontoglio; Moshe Yaniv; Alan McLachlan
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Effects of adenine arabinoside on cellular immune responses in patients with chronic hepatitis B.

Authors:  I Hyodo; G Yamada; K Manabe; H Okushin; M Mizuno; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1986-06

10.  Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment.

Authors:  Ayman M Abdelhamed; Colleen M Kelley; Thomas G Miller; Phillip A Furman; Harriet C Isom
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.